Anxiety Disorders, Comorbid Substance Abuse, and Benzodiazepine Discontinuation: Implications for Treatment

doi 10.1037/e495582006-009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Psychological Association (APA)